IBIO (IBIO)
$1.21
0.01 (0.83%)
IBIO Stock Quote Delayed 30 Minutes
7 Risky Stocks That Are Worth a Gamble
These seven A- and B-rated names are some of the top risky stocks to buy for enterprising investors. Here's what you should know about each company.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$1.51
Market Cap
14.91M
PE Ratio
-0.11
EPS
-10.5977
Volume (Avg. Vol.)
1.39M
Day's Range
$1.19 - $1.58
52-Week Range
$1.19 - $6.89
Dividend & Yield
N/A (N/A)
IBIO Stock Predictions, Articles, and IBIO News
Why iBio Stock Will Extend Its Bullish Streak
A bet on IBIO stock is a bet on its plant-based research and its FastPharming processes. IBIO is one of the hottest stocks for good reason.
Slim Vaccine Chances Make iBio Stock Too Speculative Here
Every investor is betting on a vaccine. Unfortunately, the case for IBIO stock is simply too speculative, as its trials remain under wraps.
Why Did Lincoln Park Capital Just Buy a Million Shares of iBio Stock?
Lincoln Park Capital made a huge bet on IBIO stock but will it be worth pursuing for investors who are currently on the sidelines?
Buy iBio Stock as an Effective Vaccine Could Be Imminent
Seemingly everyone in the investing world is betting on a coronavirus vaccine. Here's why IBIO stock is a great way to play that trend.
There’s Little Reason to Hold Onto iBio Stock as it Chases Latest Virus
Traders have bought up a bunch of different biotech stocks as potential coronavirus cures. iBio is one that you should get rid of while it's still up.
Why iBio Stock May Double or Triple in Value
IBIO stock is a potentially rewarding stock if customers use its manufacturing processes to scale up production of a Covid-19 vaccine.
Why iBio Stock Could Soar 500% Above Its Current Levels
IBIO stock is backed by promising technology in its efforts to make a coronavirus vaccine and a well-connected partner.
Even If You Want to Gamble, iBio Stock Is a Long Shot
While there's always a chance investors see a huge move in iBio stock, it is simply too risk for many investors at this point.
iBio Stock Is Too Risky
IBIO stock gets attention because of iBio's foray into treating the coronavirus, but investors who want that exposure should look elsewhere.
It’s Still Best to Avoid IBIO Stock Despite Any Hype
For investors in search of a novel coronavirus play, IBIO stock is looking increasingly like an extremely risky proposition.
Outlook for IBIO Stock Remains Strong as World Seeks Covid Coutermeasures
Plant-based technology could be the key to a vaccine, and IBIO stockholders could benefit as the company develops potential solutions.
The Coronavirus Makes iBio Finally Relevant
In any other circumstance, IBIO stock is an ultra-risky pharma play. With the coronavirus, it represents an economic lifeline.
IBIO Stock Is Only Worth It for High-Risk Investors
It might not be a smooth ride, but IBIO stock's potential for gains is considerable. As such, investors willing to take on the risks might profit.
IBIO Stock Dip is a 2020 Opportunity as a Bet on a Coronavirus Vaccine
Main Street is reeling from coronavirus fears, but companies are working hard to kill it. IBIO stock will prosper from management successes.
IBIO Stock may be a Hot Coronavirus Play, but Don’t Count on it Rising
IBIO stock is a hot coronavirus play, but don't count on it rising. The equity line of credit deal it signed with Lincoln Park Capital will likely lead to a lower stock price.
IBIO Stock Is a Unique and Worthy Biotech Bet
IBIO stock looks like a worthy wager on exciting plant-based solutions. Here's what prospective investors need to consider before buying.
It’s Tough to Admit, but Our New Normal Might Justify Buying IBIO Stock
IBIO stock seems like a speculative trade and it’s exactly that. However, the terrible costs associated with fighting the coronavirus makes iBio extremely relevant.
